LINCOLN, Nebraska (Nov. 3, 2021)—Jim McClurg, PhD, former Charmain of the UNeMed Board of Directors and former Regent for the University of Nebraska, was honored with BioNebraska’s first-ever Bioscience Lifetime Achievement Award during the trade organization’s annual meeting last week. McClurg—who played a significant role in the early stages of Hudl, one of Nebraska’s …

by Charles Litton, UNeMed | Jan. 11, 2016 Before moving forward it’s often useful to pause for a moment and reflect on the year that was. Here’s a review of some of the most important stories, developments, most popular posts and other highlights from UNeMed in 2015: 1. Kielian drives Innovation Week to the top …

OMAHA, Neb. (Aug. 5, 2015)—During its annual Shareholder Meeting last week, UNeMed Corporation announced four new strategic initiatives that officials expect will help expand the scope and productivity of research commercialization across the University of Nebraska Medical Center campus. Highlighted by a keynote address from UNMC Chancellor Jeffrey Gold, M.D.—and a special award presented to …

by Tom O’Connor, UNMC OMAHA, Neb. (May 28, 2015)—A key figure in the University of Nebraska Medical Center’s dramatic growth over the past three decades, Don Leuenberger announced today that he will step down in July as vice chancellor for business and finance. In his role as vice chancellor, Leuenberger, 70, was responsible for all …

by Charlie Litton, UNeMed SHANGHAI, China (November 7, 2014)—The University of Nebraska Medical Center’s relationship with China formed a stronger bond with the official opening of a satellite office in the Shanghai Free Trade Zone. A ribbon-cutting ceremony on Oct. 29 officially opened the door to deeper biomedical cooperation between UNMC and Chinese sectors in …

OMAHA, Neb. (Aug. 5, 2014)—UNeMed Corporation announced at its annual shareholder meeting that Tyler Martin, M.D., has been added to the board of directors. Martin, a product of Hebron, Neb., joins UNeMed after a long stretch of success in Silicon Valley where he helped build new startups and managed established biotech companies. His experience in …